Evidence map›Paper›PMID 28596545›Full record

ArticleScientific reports2017

Rapid on-site monitoring of Legionella pneumophila in cooling tower water using a portable microfluidic system.

Nobuyasu Yamaguchi, Yusuke Tokunaga, Satoko Goto, Yudai Fujii, Fumiya Banno, Akiko Edagawa

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Selective Detection ofBiosensors · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Frontiers in cellular and infection microbiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nobuyasu YamaguchiOsaka Institute of Public Health, 1-3-69 Nakamichi, Higashinari, Osaka, 537-0025, Japan. nyyamaguchi@iph.osaka.jp.
Yusuke TokunagaOsaka Institute of Public Health, 1-3-69 Nakamichi, Higashinari, Osaka, 537-0025, Japan.
Satoko GotoGraduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Yudai FujiiGraduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Fumiya BannoGraduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Akiko EdagawaOsaka Institute of Public Health, 1-3-69 Nakamichi, Higashinari, Osaka, 537-0025, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Legionnaires' disease, predominantly caused by the bacterium Legionella pneumophila, has increased in prevalence worldwide. The most common mode of transmission of Legionella is inhalation of contaminated aerosols, such as those generated by cooling towers. Simple, rapid and accurate methods to enumerate L. pneumophila are required to prevent the spread of this organism. Here, we applied a microfluidic device for on-chip fluorescent staining and semi-automated counting of L. pneumophila in cooling tower water. We also constructed a portable system for rapid on-site monitoring and used it to enumerate target bacterial cells rapidly flowing in the microchannel. A fluorescently-labelled polyclonal antibody was used for the selective detection of L. pneumophila serogroup 1 in the samples. The counts of L. pneumophila in cooling tower water obtained using the system and fluorescence microscopy were similar. The detection limit of the system was 10

Indexed as

GammaproteobacteriaMicrofluidicsWater MicrobiologyEnvironmental MonitoringLab-On-A-Chip DevicesMicroscopy, Fluorescence

Identifiers

PMID28596545
PMCPMC5465085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.